Stella GM - Search Results

1

RON tyrosine kinase mutations in brain metastases from lung cancer.

Milan M, Benvenuti S, Balderacchi AM, Virzì AR, Gentile A, Senetta R, Cassoni P, Comoglio PM, Stella GM. Milan M, et al. Among authors: stella gm. ERJ Open Res. 2018 Mar 6;4(1):00083-2017. doi: 10.1183/23120541.00083-2017. eCollection 2018 Jan. ERJ Open Res. 2018. PMID: 29531956 Free PMC article.

2

Targeting the MET oncogene in cancer and metastases.

Stella GM, Benvenuti S, Comoglio PM. Stella GM, et al. Expert Opin Investig Drugs. 2010 Nov;19(11):1381-94. doi: 10.1517/13543784.2010.522988. Epub 2010 Sep 26. Expert Opin Investig Drugs. 2010. PMID: 20868306 Free article. Review.

3

MET mutations in cancers of unknown primary origin (CUPs).

Stella GM, Benvenuti S, Gramaglia D, Scarpa A, Tomezzoli A, Cassoni P, Senetta R, Venesio T, Pozzi E, Bardelli A, Comoglio PM. Stella GM, et al. Hum Mutat. 2011 Jan;32(1):44-50. doi: 10.1002/humu.21374. Epub 2010 Nov 9. Hum Mutat. 2011. PMID: 20949619 Free article.

4

Epidermal growth factor receptor and caveolin-1 coexpression identifies adult supratentorial ependymomas with rapid unfavorable outcomes.

Senetta R, Miracco C, Lanzafame S, Chiusa L, Caltabiano R, Galia A, Stella G, Cassoni P. Senetta R, et al. Neuro Oncol. 2011 Feb;13(2):176-83. doi: 10.1093/neuonc/noq160. Epub 2010 Nov 8. Neuro Oncol. 2011. PMID: 21059755 Free PMC article.

5

Cancers of unknown primary origin: current perspectives and future therapeutic strategies.

Stella GM, Senetta R, Cassenti A, Ronco M, Cassoni P. Stella GM, et al. J Transl Med. 2012 Jan 24;10:12. doi: 10.1186/1479-5876-10-12. J Transl Med. 2012. PMID: 22272606 Free PMC article. Review.

6

Caveolin-1 as a promoter of tumour spreading: when, how, where and why.

Senetta R, Stella G, Pozzi E, Sturli N, Massi D, Cassoni P. Senetta R, et al. J Cell Mol Med. 2013 Mar;17(3):325-36. doi: 10.1111/jcmm.12030. Epub 2013 Mar 23. J Cell Mol Med. 2013. PMID: 23521716 Free PMC article. Review.

7

Oncogenes in non-small-cell lung cancer: emerging connections and novel therapeutic dynamics.

Stella GM, Luisetti M, Pozzi E, Comoglio PM. Stella GM, et al. Lancet Respir Med. 2013 May;1(3):251-61. doi: 10.1016/S2213-2600(13)70009-2. Epub 2013 Mar 1. Lancet Respir Med. 2013. PMID: 24429131 Review.

8

CAVEOLIN-1 expression in brain metastasis from lung cancer predicts worse outcome and radioresistance, irrespective of tumor histotype.

Duregon E, Senetta R, Pittaro A, Verdun di Cantogno L, Stella G, De Blasi P, Zorzetto M, Mantovani C, Papotti M, Cassoni P. Duregon E, et al. Oncotarget. 2015 Oct 6;6(30):29626-36. doi: 10.18632/oncotarget.4988. Oncotarget. 2015. PMID: 26315660 Free PMC article.

9

MET mutations are associated with aggressive and radioresistant brain metastatic non-small-cell lung cancer.

Stella GM, Senetta R, Inghilleri S, Verdun di Cantogno L, Mantovani C, Piloni D, Scudeller L, Meloni F, Papotti M, Ricardi U, Cassoni P. Stella GM, et al. Neuro Oncol. 2016 Apr;18(4):598-9. doi: 10.1093/neuonc/nov325. Epub 2016 Feb 23. Neuro Oncol. 2016. PMID: 26905077 Free PMC article. No abstract available.

10

Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis.

Moran S, Martínez-Cardús A, Sayols S, Musulén E, Balañá C, Estival-Gonzalez A, Moutinho C, Heyn H, Diaz-Lagares A, de Moura MC, Stella GM, Comoglio PM, Ruiz-Miró M, Matias-Guiu X, Pazo-Cid R, Antón A, Lopez-Lopez R, Soler G, Longo F, Guerra I, Fernandez S, Assenov Y, Plass C, Morales R, Carles J, Bowtell D, Mileshkin L, Sia D, Tothill R, Tabernero J, Llovet JM, Esteller M. Moran S, et al. Among authors: stella gm. Lancet Oncol. 2016 Oct;17(10):1386-1395. doi: 10.1016/S1470-2045(16)30297-2. Epub 2016 Aug 27. Lancet Oncol. 2016. PMID: 27575023

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

111 results

Search Page